GO:0002092 positive regulation of receptor internalization: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002092 describes any process that activates or increases the frequency, rate or extent of receptor internalization, a key step in signal attenuation and receptor trafficking [1, 4].
• Positive regulation of receptor internalization is driven by ligand-induced phosphorylation, ubiquitination, and recruitment of endocytic adaptors such as β-arrestin and clathrin [5, 6, 7].
• Dysregulated receptor internalization contributes to cancer, immune disorders, and neurological diseases, making it a therapeutic target [2, 6, 8].
• Key genes include GRM1, CD27, TGFBR1, FCGRs, and ADRB2, which are studied using knockout, knock-in, and overexpression models [1, 2, 6, 8].
• Flow cytometry, live-cell imaging, and proteomics are standard methods to quantify receptor internalization and identify regulatory components [4, 8].
• CRISPR-based editing enables precise dissection of positive regulators of internalization, from point mutations to tagged knock-ins [1, 2, 5].
Description
Receptor internalization is the process by which cell-surface receptors are transported into the cell, typically via clathrin-coated pits or caveolae, and it serves as a major mechanism for attenuating signaling and recycling receptors [4, 7]. Positive regulation of receptor internalization (GO:0002092) encompasses any molecular event that enhances the frequency, rate, or extent of this process, including ligand binding, receptor phosphorylation, ubiquitination, and recruitment of endocytic machinery [1, 5, 6]. This GO term is critical for understanding how cells fine-tune responses to hormones, growth factors, and neurotransmitters, and how defects in these regulatory steps can lead to disease [2, 8]. Researchers studying GPCRs, receptor tyrosine kinases, and immune receptors rely on this ontology term to annotate genes and pathways that promote internalization [1, 2, 5].
positive regulation of receptor internalization At A Glance
| GO ID | GO:0002092 |
|---|---|
| GO term | positive regulation of receptor internalization |
| Ontology | biological_process |
| Synonym | activation of receptor internalization, stimulation of receptor internalization, up regulation of receptor internalization, up-regulation of receptor internalization, upregulation of receptor internalization |
| Major function | Enhances the rate or extent of receptor internalization, often through phosphorylation, ubiquitination, and adaptor protein recruitment [5, 6, 7]. |
| Related processes | Receptor endocytosis, signal transduction attenuation, receptor recycling, and downregulation [4, 8]. |
| Key regulators | β-arrestin, GRK2, Cbl, caveolin-1, EEA1, and TRAF2 [2, 5, 6, 8]. |
| Disease relevance | Cancer, immune dysregulation, and neurological disorders [2, 6, 8]. |
What Is GO:0002092?
According to QuickGO, GO:0002092 (positive regulation of receptor internalization) is defined as any process that activates or increases the frequency, rate or extent of receptor internalization. In other words, it includes all molecular signals and cellular events that drive the movement of receptors from the plasma membrane into intracellular compartments, such as endosomes, thereby modulating signal transduction and receptor fate [4, 7].
Why Is positive regulation of receptor internalization Important in Cell Biology?
Positive regulation of receptor internalization is essential for controlling the magnitude and duration of cellular responses to external cues. It prevents excessive signaling that can lead to oncogenesis or chronic inflammation, and it governs the recycling of receptors back to the surface for repeated rounds of activation [4, 6, 7]. Understanding this process at the molecular level provides insights into drug resistance, immune evasion, and synaptic plasticity, and it offers targets for therapeutic intervention in cancer, autoimmunity, and neurodegeneration [2, 5, 8].
• Controls signal attenuation for GPCRs, RTKs, and cytokine receptors [1, 5, 7].
• Regulates immune cell activation and memory formation via CD27-TRAF2 signaling.
• Modulates TGF-β signaling by directing TGFBR1 into caveolin-1/EEA1 endosomes.
• Affects platelet-neutrophil communication through extracellular vesicles.
• Influences Fc receptor trafficking and antibody-mediated responses.
• Plays a role in synaptic plasticity and neurological disorders [1, 5].
• Is a determinant of drug efficacy for receptor-targeted therapies [4, 7].
• Provides biomarkers for receptor expression and internalization in clinical samples.
What Happens During positive regulation of receptor internalization?
Ligand binding and receptor activation
In simple terms: When a signaling molecule binds to a receptor on the cell surface, it triggers changes that prepare the receptor to be taken into the cell.
Ligand binding induces conformational changes in receptors such as metabotropic glutamate receptors, leading to activation of associated G proteins and initiation of internalization programs. For GPCRs, agonist binding promotes phosphorylation by G protein-coupled receptor kinases (GRKs), which is a prerequisite for β-arrestin recruitment [5, 7].
Phosphorylation and β-arrestin recruitment
In simple terms: Enzymes add phosphate tags to the receptor, which attract proteins like β-arrestin that help pull the receptor inside.
Receptor phosphorylation by GRKs creates high-affinity binding sites for β-arrestin, which acts as a scaffold to link the receptor to clathrin and AP-2, promoting internalization [5, 7]. This step is a key positive regulatory event and is often targeted in studies of GPCR desensitization [1, 5].
Ubiquitination and endocytic adaptor engagement
In simple terms: Adding ubiquitin chains to the receptor acts like a shipping label that directs it to the cell's internalization machinery.
Ubiquitination of Fc receptors and other immune receptors by E3 ligases such as Cbl recruits endocytic adaptors and promotes internalization. This modification is reversible and serves as a dynamic regulatory layer in receptor trafficking.
Vesicle formation and scission
In simple terms: The receptor is packaged into a small bubble called a vesicle that pinches off from the cell membrane and moves inside.
Clathrin-coated pits assemble around the receptor-adaptor complex, and dynamin mediates scission to release the vesicle into the cytoplasm [4, 6]. Caveolin-1-dependent pathways can also mediate internalization of receptors such as TGFBR1 into early endosomes positive for EEA1.
Endosomal sorting and downstream signaling
In simple terms: Once inside, the receptor can either be sent back to the surface or directed to degradation, and it can continue signaling from internal compartments.
Internalized receptors are sorted into early endosomes, where they can be recycled or targeted to lysosomes for degradation [4, 8]. In some cases, internalized receptors continue to signal from endosomes, contributing to sustained pathways such as TGF-β signaling.
Key Genes Involved in GO:0002092 positive regulation of receptor internalization
The following genes and proteins are central to positive regulation of receptor internalization, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GRM1 | Metabotropic glutamate receptor 1; undergoes internalization upon activation | Studied for allosteric modulation and neurological disorders |
| CD27 | Immune receptor that signals via TRAF2-SHP-1 to regulate internalization and gene networks | T cell memory and immune regulation |
| TGFBR1 | TGF-β type I receptor; internalizes into caveolin-1/EEA1 endosomes | Cancer and fibrosis models |
| FCGR2A | Fc gamma receptor; ubiquitination regulates endocytic trafficking | Antibody-mediated immune responses |
| ADRB2 | Beta-2 adrenergic receptor; classic GPCR internalization model | Cardiovascular and respiratory disease [5, 7] |
| ARRB1 | β-arrestin 1; scaffold for GPCR internalization | GPCR signaling and drug discovery |
| ARRB2 | β-arrestin 2; promotes receptor internalization | Neurological and metabolic studies |
| GRK2 | G protein-coupled receptor kinase 2; phosphorylates activated GPCRs | Heart failure and inflammation |
| CBL | E3 ubiquitin ligase; ubiquitinates receptors for internalization | Immune receptor trafficking |
| CAV1 | Caveolin-1; mediates caveolar internalization | TGF-β signaling and cancer |
| EEA1 | Early endosome antigen 1; marks early endosomes | Endosomal sorting studies |
| TRAF2 | E3 ligase adaptor; regulates CD27 internalization and signaling | T cell activation |
| SHP-1 | Phosphatase; modulates CD27 signaling and internalization | Immune checkpoint research |
| DNM2 | Dynamin 2; mediates vesicle scission during internalization | General endocytosis studies |
| CLTC | Clathrin heavy chain; forms coated pits | Receptor-mediated endocytosis |
| AP2M1 | AP-2 mu subunit; recruits cargo into clathrin-coated pits | Endocytic adaptor function |
| UBQLN1 | Ubiquilin 1; involved in receptor trafficking | Neurodegeneration and proteostasis |
How Is positive regulation of receptor internalization Regulated?
Positive regulation of receptor internalization is itself tightly regulated by post-translational modifications and protein-protein interactions. Phosphorylation by GRKs and ubiquitination by E3 ligases such as Cbl are reversible and can be counteracted by phosphatases and deubiquitinases [6, 7]. Allosteric modulators can enhance or inhibit internalization of specific GPCRs, as shown for metabotropic glutamate receptors. Additionally, the formation of GPCR-G protein-β-arrestin megacomplexes provides a platform for sustained signaling and internalization. In immune cells, the CD27-TRAF2-SHP-1 axis regulates internalization and downstream gene expression.
positive regulation of receptor internalization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGFBR1 | Cancer, fibrosis | Knockout and knock-in cell lines to track internalization |
| CD27 | Autoimmunity, immunodeficiency | CRISPR knockout T cells to study TRAF2-SHP-1 axis |
| FCGR2A | Autoimmune diseases | Point mutations to disrupt ubiquitination sites |
| GRM1 | Schizophrenia, anxiety | Overexpression and allosteric modulation in neuronal cells |
| ADRB2 | Heart failure, asthma | Tagged knock-in for live-cell imaging [5, 7] |
Cancer
Altered internalization of growth factor receptors such as TGFBR1 can lead to sustained oncogenic signaling. Internalization of TGFBR1 into caveolin-1/EEA1 endosomes is linked to enhanced TGF-β signaling, which promotes tumor progression and fibrosis. Targeting positive regulators of internalization may offer therapeutic strategies to dampen oncogenic pathways.
Immune disorders
Dysregulated internalization of immune receptors like CD27 and Fc gamma receptors contributes to autoimmunity and immunodeficiency. The CD27-TRAF2-SHP-1 axis controls T cell memory and activation, and its perturbation can lead to aberrant immune responses. Ubiquitination-dependent trafficking of Fc receptors is critical for antibody-mediated functions and is implicated in autoimmune diseases.
Neurological and psychiatric disorders
Metabotropic glutamate receptors (mGluRs) rely on internalization for proper synaptic signaling. Positive allosteric modulators that affect mGluR internalization are being explored for schizophrenia, anxiety, and neurodegenerative diseases. Defects in GPCR internalization can also contribute to addiction and mood disorders.
From positive regulation of receptor internalization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote receptor internalization? | CRISPR knockout of gene X followed by flow cytometry |
| Which residues are required for internalization? | Point mutations in receptor phosphorylation or ubiquitination sites |
| How does a disease-associated mutation affect trafficking? | Knock-in of mutant allele in isogenic cell lines |
| Where does the receptor localize after internalization? | Tagged knock-in with fluorescent protein |
| Does overexpression of a regulator enhance internalization? | Overexpression of wild-type or mutant regulator |
| Can a drug modulate internalization? | Allosteric modulator treatment in receptor-expressing cells [1, 5] |
How to Study the positive regulation of receptor internalization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Surface receptor levels and internalization percentage | Quantifying internalization in suspension cells |
| Live-cell imaging | Real-time receptor trafficking and colocalization | Visualizing endosomal sorting |
| Proteomics | Protein interactions and post-translational modifications | Identifying novel regulators |
| CRISPR knockout screening | Genes required for internalization | Functional genomics |
| Phosphoproteomics | Phosphorylation sites on receptors | Mapping GRK targets |
| Ubiquitin enrichment | Ubiquitinated receptor species | Studying Cbl-mediated internalization |
| FRET/BRET biosensors | Conformational changes and β-arrestin recruitment | GPCR activation studies |
| Electron microscopy | Ultrastructure of coated pits and vesicles | Morphological analysis |
Flow cytometry
Flow cytometry is a robust method to quantify receptor internalization by measuring surface receptor levels before and after stimulation. It can be combined with fluorescently labeled antibodies against specific receptors, as described for receptor internalization/shedding assays.
Live-cell imaging
Live-cell imaging with fluorescently tagged receptors allows real-time visualization of internalization dynamics and colocalization with endosomal markers such as EEA1 or caveolin-1. This method is ideal for studying the kinetics of positive regulation.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins that associate with receptors during internalization, revealing novel positive regulators. Ubiquitination and phosphorylation sites can be mapped to understand regulatory modifications [6, 7].
CRISPR screening
Genome-wide CRISPR knockout or activation screens can systematically identify genes that positively regulate receptor internalization. Such screens have been used to uncover regulators of GPCR trafficking and immune receptor endocytosis [2, 5].
How CRISPR Can Be Used to Study GO:0002092 positive regulation of receptor internalization
Knockout
CRISPR knockout of candidate genes is used to test whether they are required for positive regulation of receptor internalization. For example, knocking out ARRB1 or ARRB2 reduces GPCR internalization, confirming their positive regulatory roles. Knockout of CBL impairs ubiquitination-dependent internalization of Fc receptors.
Point Mutation
Point mutations can be introduced to disrupt specific phosphorylation or ubiquitination sites on receptors, preventing their internalization. This approach has been used to map critical residues in GPCRs and immune receptors [6, 7]. CRISPR-mediated base editing allows precise introduction of such mutations in endogenous loci.
Knock-in
Knock-in of fluorescent or epitope tags enables tracking of endogenous receptors during internalization. Tagged knock-in models for receptors like ADRB2 have been used to study trafficking in real time. Disease-associated mutations can also be knocked in to assess their impact on internalization.
Overexpression
Overexpression of wild-type or mutant regulators can enhance or disrupt internalization. For instance, overexpressing β-arrestin increases GPCR internalization, while overexpressing a dominant-negative dynamin blocks it [4, 5]. This approach is useful for gain-of-function studies.
How EDITGENE Supports positive regulation of receptor internalization Research
Researchers studying positive regulation of receptor internalization-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from gene knockout to precise point mutations and tagged knock-ins.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of receptor internalization research.
Frequently Asked Questions About positive regulation of receptor internalization
What is GO:0002092 positive regulation of receptor internalization?
GO:0002092 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of receptor internalization, the movement of receptors from the cell surface into the cell [4, 7].
What genes are involved in positive regulation of receptor internalization?
Key genes include GRM1, CD27, TGFBR1, FCGR2A, ADRB2, ARRB1, ARRB2, GRK2, CBL, CAV1, EEA1, TRAF2, and SHP-1, among others [1, 2, 5, 6, 8].
How is receptor internalization positively regulated?
It is positively regulated by ligand binding, receptor phosphorylation by GRKs, ubiquitination by E3 ligases, and recruitment of adaptors like β-arrestin and clathrin [5, 6, 7].
What diseases are associated with defects in receptor internalization?
Defects are linked to cancer, autoimmune disorders, immunodeficiency, and neurological conditions such as schizophrenia and neurodegeneration [1, 2, 6, 8].
What methods are used to study positive regulation of receptor internalization?
Common methods include flow cytometry, live-cell imaging, proteomics, and CRISPR screens [4, 5, 6, 8].
How can CRISPR be used to study receptor internalization?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes and residues involved in internalization [2, 5, 6].
What is the role of β-arrestin in receptor internalization?
β-arrestin is a scaffold protein that binds phosphorylated receptors and recruits clathrin and AP-2 to promote internalization [5, 7].
How does ubiquitination regulate receptor internalization?
Ubiquitination by E3 ligases such as Cbl tags receptors for recognition by endocytic adaptors, enhancing internalization.
What is the difference between receptor internalization and endocytosis?
Internalization is the specific process of bringing receptors into the cell, while endocytosis is the broader cellular uptake mechanism that includes receptor-mediated and fluid-phase uptake.
Can receptor internalization be measured in patient samples?
Yes, flow cytometry-based assays can measure surface receptor levels and internalization in primary cells from patients.
Conclusion
Positive regulation of receptor internalization (GO:0002092) is a fundamental biological process that controls signal transduction, receptor trafficking, and cellular responses to external stimuli. Its dysregulation is implicated in cancer, immune disorders, and neurological diseases, making it a rich area for therapeutic targeting [1, 2, 6, 8]. Advances in CRISPR-based models and imaging technologies continue to unravel the molecular players and regulatory mechanisms, offering new opportunities for drug discovery and precision medicine [5, 7].
References
- 1. Strauss A et al.. 2024. Structural basis of positive allosteric modulation of metabotropic glutamate receptor activation and internalization.. Nat Commun 15(1):6498 PMID: 39090128
- 2. Jaeger-Ruckstuhl CA et al.. 2024. Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks.. Immunity 57(2):287-302.e12 PMID: 38354704
- 3. Allan HE et al.. 2025. Platelet mitochondrial transfer via extracellular vesicles modulates neutrophil phenotype and function.. J Thromb Haemost 23(11):3665-3677 PMID: 40846030
- 4. Rigo A et al.. 2017. Flow cytometry analysis of receptor internalization/shedding.. Cytometry B Clin Cytom 92(4):291-298 PMID: 27342211
- 5. He G et al.. 2026. A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulator.. Cell 189(5):1434-1450.e22 PMID: 41605208
- 6. Molfetta R et al.. 2014. Regulation of fc receptor endocytic trafficking by ubiquitination.. Front Immunol 5:449 PMID: 25278942
- 7. Sibley DR et al.. 1987. Regulation of transmembrane signaling by receptor phosphorylation.. Cell 48(6):913-22 PMID: 3030559
- 8. He K et al.. 2015. Internalization of the TGF-β type I receptor into caveolin-1 and EEA1 double-positive early endosomes.. Cell Res 25(6):738-52 PMID: 25998683
